Caricamento...
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
BACKGROUND: Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. OBJECTIVE: This study aimed to describe the long‐term outcomes in a large cohort of patients on golimumab who had ulcerative col...
Salvato in:
| Pubblicato in: | United European Gastroenterol J |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259241/ https://ncbi.nlm.nih.gov/pubmed/33203342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620974308 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|